Onconova Therapeutics Inc (NASDAQ: ONTX) shares rose 20.7% to $1.58. Onconova Therapeutics presented positive data Monday from Phase 2 combination trial of oral Rigosertib And Azacitidine at the ASH 2015. Share volume was 4.1 million, towering over an all-day average of 319,000
